These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 15851032)

  • 21. Parametrization of macrolide antibiotics using the force field toolkit.
    Pavlova A; Gumbart JC
    J Comput Chem; 2015 Oct; 36(27):2052-63. PubMed ID: 26280362
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The structural basis of macrolide-ribosome binding assessed using mutagenesis of 23S rRNA positions 2058 and 2059.
    Pfister P; Jenni S; Poehlsgaard J; Thomas A; Douthwaite S; Ban N; Böttger EC
    J Mol Biol; 2004 Oct; 342(5):1569-81. PubMed ID: 15364582
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Time-resolved binding of azithromycin to Escherichia coli ribosomes.
    Petropoulos AD; Kouvela EC; Starosta AL; Wilson DN; Dinos GP; Kalpaxis DL
    J Mol Biol; 2009 Jan; 385(4):1179-92. PubMed ID: 19071138
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mutations outside the anisomycin-binding site can make ribosomes drug-resistant.
    Blaha G; Gürel G; Schroeder SJ; Moore PB; Steitz TA
    J Mol Biol; 2008 Jun; 379(3):505-19. PubMed ID: 18455733
    [TBL] [Abstract][Full Text] [Related]  

  • 25. RNA tertiary interactions in the large ribosomal subunit: the A-minor motif.
    Nissen P; Ippolito JA; Ban N; Moore PB; Steitz TA
    Proc Natl Acad Sci U S A; 2001 Apr; 98(9):4899-903. PubMed ID: 11296253
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Competition between erythromycin and virginiamycin for in vitro binding to the large ribosomal subunit.
    Parfait R; Di Giambattista M; Cocito C
    Biochim Biophys Acta; 1981 Jul; 654(2):236-41. PubMed ID: 6793070
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alterations at the peptidyl transferase centre of the ribosome induced by the synergistic action of the streptogramins dalfopristin and quinupristin.
    Harms JM; Schlünzen F; Fucini P; Bartels H; Yonath A
    BMC Biol; 2004 Apr; 2():4. PubMed ID: 15059283
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activities of two novel macrolides, GW 773546 and GW 708408, compared with those of telithromycin, erythromycin, azithromycin, and clarithromycin against Haemophilus influenzae.
    Kosowska K; Credito K; Pankuch GA; Hoellman D; Lin G; Clark C; Dewasse B; McGhee P; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 2004 Nov; 48(11):4113-9. PubMed ID: 15504829
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 23S rRNA 2058A-->G alteration mediates ketolide resistance in combination with deletion in L22.
    Berisio R; Corti N; Pfister P; Yonath A; Böttger EC
    Antimicrob Agents Chemother; 2006 Nov; 50(11):3816-23. PubMed ID: 16923950
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Erythromycin, Cethromycin and Solithromycin display similar binding affinities to the E. coli's ribosome: A molecular simulation study.
    Nguyen HL; An PH; Thai NQ; Linh HQ; Li MS
    J Mol Graph Model; 2019 Sep; 91():80-90. PubMed ID: 31200217
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro activities of telithromycin, linezolid, and quinupristin-dalfopristin against Streptococcus pneumoniae with macrolide resistance due to ribosomal mutations.
    Farrell DJ; Morrissey I; Bakker S; Buckridge S; Felmingham D
    Antimicrob Agents Chemother; 2004 Aug; 48(8):3169-71. PubMed ID: 15273142
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fluorescence polarization method to characterize macrolide-ribosome interactions.
    Yan K; Hunt E; Berge J; May E; Copeland RA; Gontarek RR
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3367-72. PubMed ID: 16048949
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structures of five antibiotics bound at the peptidyl transferase center of the large ribosomal subunit.
    Hansen JL; Moore PB; Steitz TA
    J Mol Biol; 2003 Jul; 330(5):1061-75. PubMed ID: 12860128
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of the ribosomal peptidyl transferase reaction by the mycarose moiety of the antibiotics carbomycin, spiramycin and tylosin.
    Poulsen SM; Kofoed C; Vester B
    J Mol Biol; 2000 Dec; 304(3):471-81. PubMed ID: 11090288
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The structure of ribosome-lankacidin complex reveals ribosomal sites for synergistic antibiotics.
    Auerbach T; Mermershtain I; Davidovich C; Bashan A; Belousoff M; Wekselman I; Zimmerman E; Xiong L; Klepacki D; Arakawa K; Kinashi H; Mankin AS; Yonath A
    Proc Natl Acad Sci U S A; 2010 Feb; 107(5):1983-8. PubMed ID: 20080686
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Macrolide-ketolide inhibition of MLS-resistant ribosomes is improved by alternative drug interaction with domain II of 23S rRNA.
    Douthwaite S; Hansen LH; Mauvais P
    Mol Microbiol; 2000 Apr; 36(1):183-93. PubMed ID: 10760175
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The structures of antibiotics bound to the E site region of the 50 S ribosomal subunit of Haloarcula marismortui: 13-deoxytedanolide and girodazole.
    Schroeder SJ; Blaha G; Tirado-Rives J; Steitz TA; Moore PB
    J Mol Biol; 2007 Apr; 367(5):1471-9. PubMed ID: 17321546
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The 3D arrangement of the 23 S and 5 S rRNA in the Escherichia coli 50 S ribosomal subunit based on a cryo-electron microscopic reconstruction at 7.5 A resolution.
    Mueller F; Sommer I; Baranov P; Matadeen R; Stoldt M; Wöhnert J; Görlach M; van Heel M; Brimacombe R
    J Mol Biol; 2000 Apr; 298(1):35-59. PubMed ID: 10756104
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Single and dual mutations at positions 2058, 2503 and 2504 of 23S rRNA and their relationship to resistance to antibiotics that target the large ribosomal subunit.
    Li BB; Wu CM; Wang Y; Shen JZ
    J Antimicrob Chemother; 2011 Sep; 66(9):1983-6. PubMed ID: 21700630
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 23S rRNA base pair 2057-2611 determines ketolide susceptibility and fitness cost of the macrolide resistance mutation 2058A-->G.
    Pfister P; Corti N; Hobbie S; Bruell C; Zarivach R; Yonath A; Böttger EC
    Proc Natl Acad Sci U S A; 2005 Apr; 102(14):5180-5. PubMed ID: 15795375
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.